Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis

Article Abstract:

It is observed that in placebo-controlled study, weekly fluconazole administered during a six-month period reduced the frequency of recurrent vulvavaginal candidiasis by more than 90 percent. In this study 387 women with recurrent vulvo-vaginal candidiasis were randomly assigned to receive treatment with fluconazole. Long-term weekly treatment with fluconazole can reduce the rate of recurrence of symptomatic vuvlavaginal candidiasis.

Science & research, Research, Diagnosis, Fluconazole

---

The effect of vaginal candidiasis on the shedding of human immunodeficiency virus in cervicovaginal secretions

Article Abstract:

The influence of symptomatic vulvovaginal candidiasis on the shedding of HIV-1 in cervicovaginal secretions of HIV-1-infected women is examined. Vulvovaginal candidiasis is found to be associated with an increased number of copies of cell-associated and cell-free HIV-1 RNA in cervicovaginal secretions in HIV-infected women.

Italy, Health aspects, Women, Risk factors, HIV patients

---

Similar abstracts:

• Abstracts: Valacyclovir therapy to reduce recurrent genital herpes in pregnant women. Comparative longitudinal study of cervical length and induced shortening changes among singleton, twin, and triplet pregnancies
• Abstracts: Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: results of a prospective cohort study
• Abstracts: Incidence and predictors of prolonged urinary retention after TVT with and without concurrent prolapse surgery

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.